Food and Drug Administration of the Philippines

A meeting between the representative/s of the Product Recall Committee and the representative/s of the MAH should be convened to discuss the next steps and the communication/s expected from each party (i.e. FDA-Public Health Advisory; MAH-Product Recall Strategy, etc.). A more thorough discussion is cited in FDA Circular 2016-012. ................
................